MONOCLONAL ANTIBODIES
- alemtuzumab (LEMTRADA, MABCAMPATH)
- anifrolumab (SAPHNELO)
- belimumab (BENLYSTA)
- inebilizumab (UPLIZNA)
- natalizumab (TYSABRI)
- ocrelizumab (OCREVUS)
- ofatumumab (KESIMPTA)
- teprotumumab (TEPEZZA)
- vedolizumab (ENTYVIO)
Using Health Canada Drug Database
updated on 11Apr2026.